Ikarian Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Ikarian Capital’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8	Closed	-$1.5K	–	345
2020 Q4	$0	Buy	+8	New	+$896	﹤0.01%	267

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Ikarian Capital's GWPH Position: Q1 2021 in Review

Ikarian Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 8 shares — an estimated $1.5K sold.

Ikarian Capital first reported a position in GWPH in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Ikarian Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Ikarian Capital sold 8 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $1.5K.
Ikarian Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2020 and held it in 1 quarter.
Ikarian Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $0 in Q4 2020.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Ikarian Capital's 13F filing for Q1 2021, filed 17 May 2021.